共 50 条
- [31] Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer [J]. Cancer Chemotherapy and Pharmacology, 2010, 65 : 589 - 595
- [33] Treatment of an Unresectable Cutaneous Squamous Cell Carcinoma With ED&C and 5-FU [J]. CUTIS, 2023, 112 (01): : E27 - E29
- [35] Defining conversion therapy for esophageal squamous cell carcinoma [J]. ANNALS OF GASTROENTEROLOGICAL SURGERY, 2023, 7 (01): : 7 - 9
- [37] Investigation of operative outcomes of thoracoscopic esophagectomy after triplet chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for advanced esophageal squamous cell carcinoma [J]. Surgical Endoscopy, 2018, 32 : 391 - 399
- [38] Investigation of operative outcomes of thoracoscopic esophagectomy after triplet chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for advanced esophageal squamous cell carcinoma [J]. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2018, 32 (01): : 391 - 399
- [39] Nimotuzumab Combined With Concurrent Chemoradiation Therapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E205 - E205